Sukamoto T, Aikawa K, Itoh K, Nose T (September 1980). “[Psychopharmacological and general pharmacological studies of 7-chloro-1-cyclopropylmethyl-1, 3-dihydro-5-(2-fluorophenyl)-2H-1, 4-benzodiazepin-2-one (KB-509) (author's transl)]”. 《Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica》 76 (6): 447–68. doi:10.1254/fpj.76.447. PMID7203280.
Ueki S, Sukamoto T, Watanabe S, Yamamoto T, Kataoka Y, Shibata S, 외. (July 1982). “[Behavioral effects of flutoprazepam (KB-509) and its metabolites]”. 《Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica》 80 (1): 15–30. doi:10.1254/fpj.80.15. PMID6890927.
Barzaghi N, Leone L, Monteleone M, Tomasini G, Perucca E (1989). “Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects”. 《European Journal of Drug Metabolism and Pharmacokinetics》 14 (4): 293–8. doi:10.1007/BF03190114. PMID2633923. S2CID20710732.
Miyaguchi H, Kuwayama K, Tsujikawa K, Kanamori T, Iwata YT, Inoue H, Kishi T (February 2006). “A method for screening for various sedative-hypnotics in serum by liquid chromatography/single quadrupole mass spectrometry”. 《Forensic Science International》 157 (1): 57–70. doi:10.1016/j.forsciint.2005.03.011. PMID15869852.
Barzaghi N, Leone L, Monteleone M, Tomasini G, Perucca E (1989). “Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects”. 《European Journal of Drug Metabolism and Pharmacokinetics》 14 (4): 293–8. doi:10.1007/BF03190114. PMID2633923. S2CID20710732.
Fukuda T, Itoh K, Nose T (March 1981). “[Antiulcerogenic action of 7-chloro-1-cyclopropylmethyl-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one (KB-509), a new benzodiazepine derivative]”. 《Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica》 77 (3): 273–80. doi:10.1254/fpj.77.273. PMID7052359.
espacenet.com
worldwide.espacenet.com
US patent 3632574, Hisao Yamamoto et al, "PROCESS FOR PRODUCING BENZODIAZEPINE DERIVATIVES", published 1968-29-04, issued 1972-04-01
“Bilingual Laws Information System”(English). The Government of the Hong Kong Special Administrative Region of the People's Republic of China.
nih.gov
ncbi.nlm.nih.gov
Sukamoto T, Aikawa K, Itoh K, Nose T (September 1980). “[Psychopharmacological and general pharmacological studies of 7-chloro-1-cyclopropylmethyl-1, 3-dihydro-5-(2-fluorophenyl)-2H-1, 4-benzodiazepin-2-one (KB-509) (author's transl)]”. 《Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica》 76 (6): 447–68. doi:10.1254/fpj.76.447. PMID7203280.
Ueki S, Sukamoto T, Watanabe S, Yamamoto T, Kataoka Y, Shibata S, 외. (July 1982). “[Behavioral effects of flutoprazepam (KB-509) and its metabolites]”. 《Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica》 80 (1): 15–30. doi:10.1254/fpj.80.15. PMID6890927.
Barzaghi N, Leone L, Monteleone M, Tomasini G, Perucca E (1989). “Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects”. 《European Journal of Drug Metabolism and Pharmacokinetics》 14 (4): 293–8. doi:10.1007/BF03190114. PMID2633923. S2CID20710732.
Miyaguchi H, Kuwayama K, Tsujikawa K, Kanamori T, Iwata YT, Inoue H, Kishi T (February 2006). “A method for screening for various sedative-hypnotics in serum by liquid chromatography/single quadrupole mass spectrometry”. 《Forensic Science International》 157 (1): 57–70. doi:10.1016/j.forsciint.2005.03.011. PMID15869852.
Barzaghi N, Leone L, Monteleone M, Tomasini G, Perucca E (1989). “Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects”. 《European Journal of Drug Metabolism and Pharmacokinetics》 14 (4): 293–8. doi:10.1007/BF03190114. PMID2633923. S2CID20710732.
Fukuda T, Itoh K, Nose T (March 1981). “[Antiulcerogenic action of 7-chloro-1-cyclopropylmethyl-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one (KB-509), a new benzodiazepine derivative]”. 《Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica》 77 (3): 273–80. doi:10.1254/fpj.77.273. PMID7052359.
semanticscholar.org
api.semanticscholar.org
Barzaghi N, Leone L, Monteleone M, Tomasini G, Perucca E (1989). “Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects”. 《European Journal of Drug Metabolism and Pharmacokinetics》 14 (4): 293–8. doi:10.1007/BF03190114. PMID2633923. S2CID20710732.
Barzaghi N, Leone L, Monteleone M, Tomasini G, Perucca E (1989). “Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects”. 《European Journal of Drug Metabolism and Pharmacokinetics》 14 (4): 293–8. doi:10.1007/BF03190114. PMID2633923. S2CID20710732.